Terms: = Sarcomas AND MTOR, FRAP2, FRAP1, 2475, ENSG00000198793, P42345, RAPT1, RAFT1, FRAP, FLJ44809 AND Prognosis
101 results:
1. Identifying squalene epoxidase as a metabolic vulnerability in high-risk osteosarcoma using an artificial intelligence-derived prognostic index.
Wang Y; Ma X; Xu E; Huang Z; Yang C; Zhu K; Dong Y; Zhang C
Clin Transl Med; 2024 Feb; 14(2):e1586. PubMed ID: 38372422
[TBL] [Abstract] [Full Text] [Related]
2. LncRNA RPARP-AS1 promotes the progression of osteosarcoma cells through regulating lipid metabolism.
Cai F; Liu L; Bo Y; Yan W; Tao X; Peng Y; Zhang Z; Liao Q; Yi Y
BMC Cancer; 2024 Feb; 24(1):166. PubMed ID: 38308235
[TBL] [Abstract] [Full Text] [Related]
3. Lnc-PSMA8-1 activated by GEFT promotes rhabdomyosarcoma progression via upregulation of mtor expression by sponging miR-144-3p.
Meng L; Shang H; Liu Q; Li Z; Wang X; Li Q; Li F; Zhao Z; Liu C
BMC Cancer; 2024 Jan; 24(1):79. PubMed ID: 38225540
[TBL] [Abstract] [Full Text] [Related]
4. Solute carrier family 35 member A2 regulates mitophagy through the PI3K/AKT/mtor axis, promoting the proliferation, migration, and invasion of osteosarcoma cells.
Luo X; Zhang J; Guo C; Jiang N; Zhang F; Jiao Q; Xu K; Yang J; Qu G; Lv XB; Zhang Z
Gene; 2024 Mar; 898():148110. PubMed ID: 38151177
[TBL] [Abstract] [Full Text] [Related]
5. Factors predictive of second-line chemotherapy in soft tissue sarcoma: An analysis of the National Genomic Profiling Database.
Mochizuki T; Ikegami M; Akiyama T
Cancer Sci; 2024 Feb; 115(2):575-588. PubMed ID: 38115234
[TBL] [Abstract] [Full Text] [Related]
6. RILP inhibits tumor progression in osteosarcoma via Grb10-mediated inhibition of the PI3K/AKT/mtor pathway.
Wei Z; Xia K; Zheng D; Gong C; Guo W
Mol Med; 2023 Oct; 29(1):133. PubMed ID: 37789274
[TBL] [Abstract] [Full Text] [Related]
7. The Targeted Therapies for Osteosarcoma
Wang S; Ren Q; Li G; Zhao X; Zhao X; Zhang Z
Curr Mol Pharmacol; 2024; 17(1):e210823220109. PubMed ID: 37602543
[TBL] [Abstract] [Full Text] [Related]
8. Systemic Treatments and Molecular Biomarkers for Perivascular Epithelioid Cell Tumors: A Single-institution Retrospective Analysis.
Testa S; Bui NQ; Ganjoo KN
Cancer Res Commun; 2023 Jul; 3(7):1212-1223. PubMed ID: 37448552
[TBL] [Abstract] [Full Text] [Related]
9. A Phase I/II Investigation of Safety and Efficacy of Nivolumab and
Gordon EM; Angel NL; Omelchenko N; Chua-Alcala VS; Moradkhani A; Quon D; Wong S
Anticancer Res; 2023 May; 43(5):1993-2002. PubMed ID: 37097693
[TBL] [Abstract] [Full Text] [Related]
10. A tumor microenvironment-based prognostic index for osteosarcoma.
Wu C; Gong S; Duan Y; Deng C; Kallendrusch S; Berninghausen L; Osterhoff G; Schopow N
J Biomed Sci; 2023 Apr; 30(1):23. PubMed ID: 37055822
[TBL] [Abstract] [Full Text] [Related]
11. Primary and secondary angiosarcomas of the liver: a multi-institutional study of 32 cases.
Liao X; Lai J; Lin J; Zhang D
Hum Pathol; 2023 Jul; 137():10-17. PubMed ID: 37054784
[TBL] [Abstract] [Full Text] [Related]
12. Kaposi sarcoma at the base of the tongue in a renal transplant patient.
Safia A; Farhat R; Avraham Y; Merchavy S
BMJ Case Rep; 2023 Mar; 16(3):. PubMed ID: 36882263
[TBL] [Abstract] [Full Text] [Related]
13. Biology and Management of High-Grade Chondrosarcoma: An Update on Targets and Treatment Options.
Tlemsani C; Larousserie F; De Percin S; Audard V; Hadjadj D; Chen J; Biau D; Anract P; Terris B; Goldwasser F; Pasmant E; Boudou-Rouquette P
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674874
[TBL] [Abstract] [Full Text] [Related]
14. Aa-Z2 triggers ROS-induced apoptosis of osteosarcoma by targeting PDK-1.
Liu Y; She W; Li Y; Wang M; Liu Y; Ning B; Xu T; Huang T; Wei Y
J Transl Med; 2023 Jan; 21(1):7. PubMed ID: 36611209
[TBL] [Abstract] [Full Text] [Related]
15. Comprehensive molecular profiling of sarcomas in adolescent and young adult patients: Results of the EORTC SPECTA-AYA international proof-of-concept study.
Morfouace M; Horak P; Kreutzfeldt S; Stevovic A; de Rojas T; Denisova E; Hutter B; Bautista F; Oliveira J; Defachelles AS; White J; Kasper B; Preusser M; Golfinopoulos V; Pfister S; Van der Graaf W; Wardelmann E; Shenjere P; Fröhling S; McCabe MG
Eur J Cancer; 2023 Jan; 178():216-226. PubMed ID: 36470093
[TBL] [Abstract] [Full Text] [Related]
16. The COPS3-FOXO3 positive feedback loop regulates autophagy to promote cisplatin resistance in osteosarcoma.
Niu J; Yan T; Guo W; Wang W; Ren T; Huang Y; Zhao Z; Yu Y; Chen C; Huang Q; Lou J; Guo L
Autophagy; 2023 Jun; 19(6):1693-1710. PubMed ID: 36451342
[TBL] [Abstract] [Full Text] [Related]
17. Visfatin-Induced Inhibition of miR-1264 Facilitates PDGF-C Synthesis in Chondrosarcoma Cells and Enhances Endothelial Progenitor Cell Angiogenesis.
Song CY; Chang SL; Lin CY; Tsai CH; Yang SY; Fong YC; Huang YW; Wang SW; Chen WC; Tang CH
Cells; 2022 Nov; 11(21):. PubMed ID: 36359873
[TBL] [Abstract] [Full Text] [Related]
18. Chloroquine Combined With Rapamycin Arrests Tumor Growth in a Patient-derived Orthotopic Xenograft (PDOX) Mouse Model of Dedifferentiated Liposarcoma.
Masaki N; Aoki Y; Kubota Y; Obara K; Miyazaki J; Hoffman RM
In Vivo; 2022; 36(6):2630-2637. PubMed ID: 36309387
[TBL] [Abstract] [Full Text] [Related]
19. The Role of Cytoreductive Nephrectomy in Renal Cell Carcinoma with Sarcomatoid Histology: A Case Series and Review of the Literature.
Studentova H; Rusarova N; Ondruskova A; Zemankova A; Student V; Skanderova D; Melichar B
Curr Oncol; 2022 Aug; 29(8):5475-5488. PubMed ID: 36005171
[TBL] [Abstract] [Full Text] [Related]
20. Nitazoxanide inhibits osteosarcoma cells growth and metastasis by suppressing AKT/mtor and Wnt/β-catenin signaling pathways.
Ye C; Wei M; Huang H; Wang Y; Zhang L; Yang C; Huang Y; Luo J
Biol Chem; 2022 Sep; 403(10):929-943. PubMed ID: 35946850
[TBL] [Abstract] [Full Text] [Related]
[Next]
